Noticias de EDIT_US

Noticias del mercado

Últimas noticias sobre EDIT_US — 208 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: EDIT_US ✕ 208 resultados
23/04/2026 EDIT_US — GlobeNewswire ES ← EN
Adjunto

Attachment

22/04/2026 EDIT_US — MarketBeat
Editas Medicine (NASDAQ:EDIT) Share Price Passes Above 50 Day Moving Average - Here's What Happened
17/04/2026 EDIT_US — MarketScreener
Editas Medicine : Corporate Effectiveness Report April 2026 (b08b29)
13/04/2026 EDIT_US — MarketBeat
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Recommendation of "Moderate Buy" from Analysts
08/04/2026 EDIT_US — Yahoo Finance
Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?
08/04/2026 EDIT_US — Minichart
Editas Medicine, Inc. Files Form 8-K Announcing Changes in Certifying Accountant – April 2026
08/04/2026 EDIT_US — Investing.com ES ← EN
Editas Medicine nombra a PwC nuevo auditor y despide a Ernst & Young
07/04/2026 EDIT_US — Stock Titan
Audit shakeup at Editas Medicine (NASDAQ: EDIT) as PwC replaces Ernst & Young
07/04/2026 EDIT_US — Investing.com
Editas Medicine appoints PwC as new auditor, dismisses Ernst & Young
07/04/2026 EDIT_US — Investing.com
Editas Medicine appoints PwC as new auditor, dismisses Ernst & Young By Investing.com
07/04/2026 EDIT_US — Investing.com
Editas Medicine appoints PwC as new auditor, dismisses Ernst & Young
06/04/2026 EDIT_US — sonla.gov.vn
Should I Buy Editas Medicine (EDIT) Stock in 2026 | Price at $2.72, Up 1.87% - Investment Signal Network
06/04/2026 EDIT_US — news.google.com
Can Editas Medicine (EDIT) Stock Beat the Market | Price at $2.73, Up 2.25% - Institutional Grade Picks
06/04/2026 EDIT_US — Xã Thanh Hà
Should I Buy Editas Medicine (EDIT) Stock in 2026 | Price at $2.72, Up 1.87% - Investment Signal Network
06/04/2026 EDIT_US — Xã Châu Thành
Can Editas Medicine (EDIT) Stock Beat the Market | Price at $2.73, Up 2.25% - Institutional Grade Picks
04/04/2026 EDIT_US — MSN ES ← EN
Las acciones de Editas Medicine suben después de las estimaciones máximas de ganancias e ingresos del cuarto trimestre
04/04/2026 EDIT_US — Intellectia AI
EDIT Should I Buy
30/03/2026 EDIT_US — AD HOC NEWS
Editas Medicine Inc Stock: Genome Editing Pioneer Faces Key Milestones in Competitive Biotech Landsc
27/03/2026 EDIT_US — Yahoo Finance
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
27/03/2026 EDIT_US — Stock Titan
CRISPR patent win bolsters Editas Medicine (NASDAQ: EDIT) IP estate

Página 10 de 11

keyboard_arrow_up